Three‐Year Outcome of Drug Coated Balloon Angioplasty Following Atherectomy for Severely Calcified Coronary Lesions
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70196 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Taka-Aki Takamura und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Kanazawa Medical University, Uchinada, Japan. Hauptthemen laut MEDLINE: Atherectomy, Coronary, Coronary Artery Disease, Vascular Calcification, Coated Materials, Biocompatible. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
We aimed to compare the long‐term efficacy and safety of drug‐coated balloon (DCB) and drug‐eluting stent (DES) following atherectomy for coronary arteries with severely calcified lesions. Of the 258 consecutive patients and 422 de novo lesions treated with DCB at Kanazawa Medical University Hospital, we retrospectively enrolled highly calcified de novo lesions treated with atherectomy, rotablator, and/or orbital atherectomy system (OAS), followed by the use of either DCB (94 cases, 191 lesions) or DES (159 cases, 216 lesions) were retrospectively examined. The primary endpoint was target lesion revascularization (TLR), and the secondary endpoint was major adverse cardiac event (MACE) during 3 years of follow‐up. Regarding patient background, there was a significant difference in age (All DCB vs. DES: 69.5 ± 11.4 vs. 73.2 ± 8.6; p < 0.001), and the DCB group included more dialysis cases (28.3% vs. 15.3%; p < 0.01). No significant difference was observed in the lesion background. The balloon size of the DCB was 2.56 ± 0.40 mm. Acute closure was not observed after DCB. Late lumen loss (LLL) was −0.07 ± 0.34 mm (DCB) versus 0.46 ± 0.65 mm (DES). Late lumen engagement (LLE) was observed in 56 lesions (56/129 [43.4%]) in the DCB group. As adjunctive treatment after atherectomy for calcified lesions, no significant difference was observed in TLR (16.2% vs. 13.4%; log‐rank, p = 0.08) and MACE (18.3% vs. 16.2%; log‐rank, p = 0.13). For highly calcified coronary lesions, relative to DES, treatment with DCB after atherectomy could provide clinically acceptable favorable results in terms of TLR and MACE at 3 years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Kanazawa Medical University, Uchinada, Japan.
- Division of Medical Engineer, Kanazawa Medical University, Uchinada, Japan.
ORCID-Profile: Taka-Aki Takamura, Taketsugu Tsuchiya
Zitieren
APA
Takamura, T. A., Nakagawa, C., Masaki, M., Akita, S., Oda, M., Wakasa, M., Akao, H., Kitayama, M., Tsuchiya, T., Ichikawa, T., Takama, S., & Nakagawa, T. (2025). Three‐Year Outcome of Drug Coated Balloon Angioplasty Following Atherectomy for Severely Calcified Coronary Lesions. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70196
Vancouver
Takamura TA, Nakagawa C, Masaki M, Akita S, Oda M, Wakasa M, et al. Three‐Year Outcome of Drug Coated Balloon Angioplasty Following Atherectomy for Severely Calcified Coronary Lesions. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70196
BibTeX
@article{Takamura2025,
author = {Takamura, Taka-Aki and Nakagawa, Chihiro and Masaki, Miharu and Akita, Satori and Oda, Minako and Wakasa, Minoru and Akao, Hironobu and Kitayama, Michihiko and Tsuchiya, Taketsugu and Ichikawa, Toshiki and Takama, Shunsuke and Nakagawa, Tohru},
title = {Three‐Year Outcome of Drug Coated Balloon Angioplasty Following Atherectomy for Severely Calcified Coronary Lesions},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70196}
}
EUVIMED